NCT06470204View on ClinicalTrials.gov

Dexamethasone for iPACK Block With ACB in Total Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 13, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

March 30, 2025

Conditions
Knee OsteoarthritisKnee Pain ChronicKnee Arthritis
Interventions
DRUG

Ropivacaine

Ultrasound-guided iPACK block + ACB - 2 x (20ml 0,2% ropivacaine + 2ml 0.9% NaCl)

DRUG

Ropivacaine+Dexamethasone

Ultrasound-guided iPACK block + ACB - 2 x (20ml 0,2% ropivacaine + 2mg Dexamethasone)

Trial Locations (1)

61-701

Poznan University of Medical Sciences, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT06470204 - Dexamethasone for iPACK Block With ACB in Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter